大连医科大学学报
大連醫科大學學報
대련의과대학학보
JOURNAL OF DALIAN MEDICAL UNIVERSITY
2014年
3期
274-276
,共3页
蒋思雄%王文%孙卫兵%于洋%王志俊%杨玻
蔣思雄%王文%孫衛兵%于洋%王誌俊%楊玻
장사웅%왕문%손위병%우양%왕지준%양파
良性前列腺增生%经尿道前列腺电切%经尿道等离子前列腺剜除
良性前列腺增生%經尿道前列腺電切%經尿道等離子前列腺剜除
량성전렬선증생%경뇨도전렬선전절%경뇨도등리자전렬선완제
benign prostatic hyperplasia%transurethral resection of prostate%transurethral plasmakinetic enucleation of the prostate
目的:探讨经尿道等离子双极电刀前列腺剜除(PKEP)治疗良性前列腺增生(BPH)的临床应用。方法选择大连医科大学附属第二医院2012年11月-2013年5月,具有手术指征,单纯的BPH患者共计140例,年龄61~84岁,平均68.6岁,随机分为2组。PKEP组(60例)行经尿道等离子双极电刀前列腺剜除术(PKEP),TURP组(80例)行经尿道前列腺电切术(TURP)。统计每例患者术前国际前列腺症状评分(IPSS)、生活质量评分(QOL)和最大尿流率(Qmax),手术时间、术中术后有无并发症、输血,术后尿管留置时间、平均住院日及术后2周IPSS、QOL、Qmax。结果两组IPSS、QOL、Qmax术前术后比较差异有显著性意义(P<0.05),但两组间比较无明显差异(P>0.05)。两组平均手术时间差异无显著性意义(P>0.05),PKEP组和TURP组患者平均尿管留置时间分别为(46.2±12.5)h和(92.6±20.8)h;平均住院日分别为(7.2±2.4)d和(9.1±2.1)d。两组比较差异有显著性意义(P<0.05)。所有患者术中术后均无输血,TURP组患者术中3例出现电切综合征(TURS)。结论等离子腔内前列腺剜除手术安全、有效,且具有术后尿管留置时间少及住院时间短等优点,可作为治疗BPH的一种选择。
目的:探討經尿道等離子雙極電刀前列腺剜除(PKEP)治療良性前列腺增生(BPH)的臨床應用。方法選擇大連醫科大學附屬第二醫院2012年11月-2013年5月,具有手術指徵,單純的BPH患者共計140例,年齡61~84歲,平均68.6歲,隨機分為2組。PKEP組(60例)行經尿道等離子雙極電刀前列腺剜除術(PKEP),TURP組(80例)行經尿道前列腺電切術(TURP)。統計每例患者術前國際前列腺癥狀評分(IPSS)、生活質量評分(QOL)和最大尿流率(Qmax),手術時間、術中術後有無併髮癥、輸血,術後尿管留置時間、平均住院日及術後2週IPSS、QOL、Qmax。結果兩組IPSS、QOL、Qmax術前術後比較差異有顯著性意義(P<0.05),但兩組間比較無明顯差異(P>0.05)。兩組平均手術時間差異無顯著性意義(P>0.05),PKEP組和TURP組患者平均尿管留置時間分彆為(46.2±12.5)h和(92.6±20.8)h;平均住院日分彆為(7.2±2.4)d和(9.1±2.1)d。兩組比較差異有顯著性意義(P<0.05)。所有患者術中術後均無輸血,TURP組患者術中3例齣現電切綜閤徵(TURS)。結論等離子腔內前列腺剜除手術安全、有效,且具有術後尿管留置時間少及住院時間短等優點,可作為治療BPH的一種選擇。
목적:탐토경뇨도등리자쌍겁전도전렬선완제(PKEP)치료량성전렬선증생(BPH)적림상응용。방법선택대련의과대학부속제이의원2012년11월-2013년5월,구유수술지정,단순적BPH환자공계140례,년령61~84세,평균68.6세,수궤분위2조。PKEP조(60례)행경뇨도등리자쌍겁전도전렬선완제술(PKEP),TURP조(80례)행경뇨도전렬선전절술(TURP)。통계매례환자술전국제전렬선증상평분(IPSS)、생활질량평분(QOL)화최대뇨류솔(Qmax),수술시간、술중술후유무병발증、수혈,술후뇨관류치시간、평균주원일급술후2주IPSS、QOL、Qmax。결과량조IPSS、QOL、Qmax술전술후비교차이유현저성의의(P<0.05),단량조간비교무명현차이(P>0.05)。량조평균수술시간차이무현저성의의(P>0.05),PKEP조화TURP조환자평균뇨관류치시간분별위(46.2±12.5)h화(92.6±20.8)h;평균주원일분별위(7.2±2.4)d화(9.1±2.1)d。량조비교차이유현저성의의(P<0.05)。소유환자술중술후균무수혈,TURP조환자술중3례출현전절종합정(TURS)。결론등리자강내전렬선완제수술안전、유효,차구유술후뇨관류치시간소급주원시간단등우점,가작위치료BPH적일충선택。
Objective To evaluate clinical application of transurethral plasmakinetic enucleation of the prostate ( PKEP) in the treatment of benign prostatic hyperplasia ( BPH) .Methods A total of 140 BPH patients in our hospital , aged 61-84 (mean 68.6) years, with indication of surgery, underwent transurethral plasmakinetic enucleation of the prostate (PKEP group, n=60) or transurethral resection of prostate (TURP group, n=80).Pre-and post-operative International Pros-tate Symptom Score ( IPSS ) , quality of life ( QOL ) and maximum urinary flow rates ( Qmax ) , as well as intra -and post-operative bleeding and complications were recorded and analyzed .Results There were significant differences between pre-and post-operative IPSS,QOL and Qmax in both PKEP and TURP groups (P<0.05).However, the values were not significantly different when compared between the two groups (P>0.05).The operation times were not significantly differ-ent between the two groups.The mean time of hospitalization was (7.2 ±2.4)d in PKEP group, versus (9.1 ±2.1)d in TURP group, and the duration of catheterization was (46.2 ±12.5) h and (92.6 ±20.8) h, respectively(P<0.05). One hundred patients did not receive blood transfusion both intra -and post -operation .Three patients in TURP group were complicated by mild intra -operative transurethral resection syndrome ( TURS) .Conclusion PKEP is a safe and ef-fective procedure , which has less time of mean hospitalization and catheterization .PKEP can be chosen as surgical treat-ment for BPH .